Some diseases are untreatable because we lack a model system to fully understand symptoms or test possible drugs. This is the case of mitochondrial disease, a rare condition caused by defects in the “cellular powerhouse.” MDC scientists developed the first human stem-cell based system to find drugs to fight mitochondrial disease.
Archives for January 2017
Researchers at the MDC have developed antibodies that promise to heal multiple myeloma. The biotechnology company Heidelberg Pharma will now develop one of these antibodies to an antibody-toxin agent and test it clinically at the end of 2018.
On this day 25 years ago, the MDC was officially named after the geneticist Max Delbrück. Many things have changed since then. The MDC’s Director Martin Lohse looks forward into the future: What will the research center look like in 2042?
If one looks beyond individual molecules, biology quickly becomes complex. Computer scientist Uwe Ohler are using algorithms and mathematical models to map a path through this tangle of dependencies.
David H. Gutmann, the US neurologist, and Prof. Maike Sander, a diabetes researcher at the University of California, San Diego, USA, have now been granted the Humboldt Research Award by the Alexander von Humboldt Foundation.
“Ideally as a postdoc you should aim to publish as last as well as first author and gather experience writing grants,” says Professor Yves Muller. The crystallographer emphasises that postdocs wanting to become group leads need to enjoy independence and be ready to follow their own ideas.
The Berlin-Nord Study Centre has now recruited half of the 10,000 volunteers for Germany’s largest ever cohort study, the NAKO Health Study. It serves the improvement of prevention, early detection and treatment of widespread diseases.
The next Horizon – Strategies to promote European competitiveness in innovation